Such studies could provide additional insight into the contributions of the AKAP5/P2Y11/AC5/PKA/CaV1.2 nanocomplex in the development of vascular complications during chronic hyperglycemia and diabetes. This evidence concerns the gene CAV1 and diabetes mellitus.